AzTrials
AzTrials

Pulpitis - IrreversibleNCT05402098

Outcome Following Endodontic Treatment Using Traditional Access Versus Conservative Access

A study testing Endodontic treatment using traditional access and Endodontic treatment using conservative access in people with Pulpitis - Irreversible, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will compare the outcome of endodontic treatment using conservative or traditional access design in permanent molars with clinical signs indicative of irreversible pulpitis Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Pulpitis - Irreversible
What is being tested?
Endodontic treatment using traditional access and Endodontic treatment using conservative access
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
92 participants
Where
1 siteIndia
Study dates
12 May 2022to Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • The patient should be ≥18 years of age.
  • Restorable mandibular molars with extremely deep caries involving occlusal surface only
  • Clinical diagnosis of symptomatic irreversible pulpitis with PAI score ≤2.
  • Tooth should give positive response to pulp sensibility testing.
  • Tooth with probing pocket depth and mobility are within normal limits.
  • Non-contributory medical history.

Who cannot join

  • Teeth with immature roots.
  • No pulp exposure even after caries excavation.
  • Teeth with signs of pulpal necrosis including sinus tract or swelling.
  • Teeth with percussion sensitivity
  • Positive history of antibiotic use in the past 1 month or requiring antibiotic prophylaxis
  • Had taken analgesic in past 3 days
Show all 10Show fewer
  • Teeth with pathologic changes such as internal or external resorption
  • Teeth with morphological variation
  • Teeth with root canal calcification
  • Teeth with fixed full coverage prosthesis

Trial locations and contacts

1 site in 1 country.

DR. ANKITA RAMANI, MDS contact

+919582841539

ramaniankita95@gmail.com

DR. PANKAJ SANGWAN, MDS contact

9996112202

drps_1@yahoo.com

India1 site, 1 recruiting
  • Dr. Ankita Ramani

    Rohtak, Haryana, 124001

    DR. ANKITA RAMANI, MDS, 09582841539, ramaniankita95@gmail.com

    Recruiting

Other trials in India

About this study

Official title: Comparative Evaluation of Outcome Following Endodontic Treatment Using Traditional Versus Conservative Access in Mandibular Molars With Symptomatic Irreversible Pulpitis: a Randomized Controlled Trial

This study will compare the outcome of endodontic treatment using conservative or traditional access design in permanent molars with clinical signs indicative of irreversible pulpitis

Read the detailed description

After thorough history and clinical and radio graphic examination, and confirmation of eligibility for the study, written informed consent will be obtained after explaining the procedure and its associated risks and benefits.

Clinical diagnosis of symptomatic irreversible pulpitis will be established based on a history of spontaneous pain or pain exacerbated by cold stimuli and lasting for a few seconds to several hours (lingering pain) compared to control teeth and which is reproducible using cold testing.

Once included, study subjects will be randomly allocated to either traditional access or conservative access group. Subsequently biomechanical preparation will be carried out using standard protocol with the use of rotary NiTi file system followed by root canal filling using gutta percha and zinc oxide eugenol sealer. Teeth will be restored using composite resin in the same appointment.

Pain analysis will be carried out preoperatively and postoperatively at every 24 hours till 7 days after intervention. All the subjects will be followed up for evaluation of success at 6 and 12 months from baseline.

Being tested
Endodontic treatment using traditional access, Endodontic treatment using conservative access
Keywords
Irreversible pulpitis, Endodontic treatment, Traditional access, Conservative access, Contracted endodontic cavities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endodontic treatment using traditional accessProcedure or surgery

    Endodontic treatment will be carried out following complete removal of pulp chamber roof and achieving straight line access

  • Endodontic treatment using conservative accessProcedure or surgery

    Endodontic treatment will be carried out following partial removal of pulp chamber roof, extended only to the extent which helps to locate all the orifices with no efforts will be made to achieve straight line access

Study groups in NCT05402098
Study groupRoleWhat they receive
Endodontic treatment using traditional accessActive comparatorStraight line access will be achieved following complete removal of pulp chamber roof
Receives: Procedure: Endodontic treatment using traditional access
Endodontic treatment using conservative accessExperimentalPart of pulp chamber roof will be preserved and no efforts will be directed to achieve straight line access
Receives: Procedure: Endodontic treatment using conservative access

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical and radiographic success

    CLINICAL SUCCESS CRITERIA:

    Absence of spontaneous pain, discomfort, swelling, sinus tract or tenderness to palpation or percussion.

    RADIOGRAPHIC SUCCESS CRITERIA:

    No pathosis evident on the radiograph such as root resorption, furcal pathosis or new periapical pathosis.

    Periapical Index score 1 or 2 according to Orstavic et al. Evaluation of both clinical and radiographic outcome is must for analyzing the actual success of therapeutic technique.

    Number of participants fulfilling both clinical as well as radiographic success criteria will be considered in success category.

    Measured: Baseline to 12 Months

Secondary outcomes (1)
  1. Pain analysis

    To assess incidence and intensity of pain postoperatively at every 24 hours till 7 days using Visual analogue Scale of 0 to 100 Millimeter line. Score 0 means no pain and Score 100 means maximum pain.

    Measured: Baseline to 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2022
  2. Study start12 May 2022
  3. Primary completionSep 2023 (estimated)
  4. Study completionSep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
92 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05402098
Sponsor's protocol ID
A Ramani
Status last verified
May 2022
First submitted
29 May 2022
Last updated
2 Jun 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Endodontic treatment using traditional access and Endodontic treatment using conservative access in people with Pulpitis - Irreversible, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact DR. ANKITA RAMANI, MDS (+919582841539, ramaniankita95@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical and radiographic success (time frame: Baseline to 12 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in